InvestorsHub Logo

MontanaState83

05/15/20 8:21 AM

#273847 RE: eightisenough #273844

Eight - "you believe amrn mgmt do better job?" Good Lord, No

My concern is they do an EU partner deal and then lose the appeal. If that happens AMRN becomes a shell of a company collecting royalties.

I'm no lawyer, but winning the appeal still seems like a long shot as politics, left vs right, etc. seem to weigh far more than the truth or the law. My faith in the legal system (in this regard) is pretty much nill.

Given the above, I just want the company sold.

ziploc_1

05/15/20 8:45 AM

#273850 RE: eightisenough #273844

eight...QUOTE"-if you believe we will win the appeal--its best for the sp to get a boost with EU partnership"

Let's assume Amarin loses the appeal ...Their next move would be to entertain offers for an EU partnership...or a BO by a BP, who would market Vascepa as a Generic or OTC in the US...and as a branded drug in the EU...Amarin would then have a choice as to which deal would make more sense...(partnership or BO)...

If Amarin wins the appeal...which is looking more likely after the Singer brief...they will then have the options to GIA in the US and in the EU...as well the options for a EU partnership or a BO.

I doubt that Amarin will make any moves before they know the outcome of the appeal.